Denovo Biopharma

6404 Nancy Ridge Drive
San Diego
United States


Show jobs for this employer

About Denovo Biopharma

Denovo Biopharma is a privately-held biotechnology company that provides novel and proprietary biomarker approaches to personalized drug development, including re-evaluating medicines that have failed in general patient populations and studying them in the original indication in biomarker-selected sub-populations. The company offers the first platform and algorithm for de novo genomic biomarker discovery using archived clinical samples. This technology may be especially useful for compounds with suboptimal late-stage trial results. By identifying biomarkers correlated with patients' responses to drug candidates retrospectively, Denovo enables the design and execution of follow-on clinical trials in targeted patient populations with increased likelihood of success.
CEO: Wen Luo
COO: Xiangming Fang
CBO: Robert Little

7 articles with Denovo Biopharma